Related Party Transactions |
9 Months Ended |
|---|---|
Sep. 30, 2026 | |
| Related Party Transactions [Abstract] | |
| Related Party Transactions | 11. RELATED PARTY TRANSACTIONS Related parties include the Company’s directors, executive officers, principal stockholders, and members of their immediate families; entities controlled by, or under significant influence of, any of these parties; and other parties that can significantly influence the management or operating policies of the Company. Scientific Advisory Board Member One of the Company’s co-founders and former director was a member of the Company’s Scientific Advisory Board through May 2026, when the Company terminated its agreement with this related party. The Company incurred expense of $0.1 million for advisory services provided during each of the nine month periods ended September 30, 2026 and 2025. The Company incurred no expense for advisory services provided by this related party during the three months ended September 30, 2026, compared to $0.1 million during the three months ended September 30, 2025. License Agreement One of the Company’s co-founders, who is a current director and principal stockholder of the Company, is a professor at Harvard Medical School. Intellectual property utilized by the Company is licensed from Harvard under the License Agreement described in Note 9, License Agreements. As a result, Harvard is considered a related party. The Company incurred expense of $0.1 million related to the License Agreement during each of the three and nine month periods ended September 30, 2026 and 2025. |